Recombinant sendai virus vector for introducing exogenous genes to airway epithelia
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 1, 2008
Grant Date -
N/A
app pub date -
Nov 2, 2000
filing date -
Nov 2, 1999
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Provided are a recombinant Sendai virus vector for introducing exogenous genes to airway epithelia and a method for introducing exogenous genes using the vector. The recombinant Sendai virus vector enables efficient gene transfer to native mucus-layered airway epithelial cells by briefly contacting the vector with the cells. Furthermore, the vector can introduce genes to not only apical surfaces but also submucosal glands where CFTR primarily expresses. The vector can thus be used for gene therapy of CF, a CFTR-deficient disease.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully